Skip to main content
. 2023 Sep 12;9(10):2025–2035. doi: 10.1021/acsinfecdis.3c00324

Figure 2.

Figure 2

Metabolic inhibitors disrupt glycan biosynthesis. (A) Schematic of benzyl glycosides acting as metabolic inhibitors to divert glycan biosynthesis onto decoy substrates, ultimately leading to truncated glycans on bacteria. (B) Precedented O-glycoside inhibitors from previous work. (C) Novel S-glycoside analogues of bacterial sugar scaffolds used as putative metabolic inhibitors in this study.